PCAR
45
3
DD
40
4
MTCH
55
18
SYF
64
2
NOV
49
5
AVB
52
5
AES
35
-2
PNR
50
3
MAT
58
-5
STI
1
-12
MCO
64
3
NKE
33
3
TXN
42
9
NSC
39
3
TSN
24
4
PFG
31
4
MTB
44
3
LOW
42
2
DHI
35
2
HST
37
2
PCAR
45
3
DD
40
4
MTCH
55
18
SYF
64
2
NOV
49
5
AVB
52
5
AES
35
-2
PNR
50
3
MAT
58
-5
STI
1
-12
MCO
64
3
NKE
33
3
TXN
42
9
NSC
39
3
TSN
24
4
PFG
31
4
MTB
44
3
LOW
42
2
DHI
35
2
HST
37
2
Financhill
Back

First Resources Vs. Blueprint Medicines Industry Stock Comparison

Buy
83

FTROF
First Resources

Last Price:
$1.23
Seasonality Move:
0%
Sell
43

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Buy
83
First Resources (FTROF) is a Buy

Is First Resources a Buy, Sell or Hold?

  • The current First Resources [FTROF] share price is $1.23. The Score for FTROF is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • FTROF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FTROF Stock Price Chart

What is First Resources's stock price today?

  • The First Resources share price today is $1.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTROF is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $103.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

FTROF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 82.61 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.54 - 1) Buy
Bollinger Bands (100): (0.84 - 1.22) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 65.19 Buy
Chaikin Money Flow: 1951173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.25 - 95.81) Buy
Bollinger Bands (100): (87.04 - 95.76) Buy

FTROF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.79 Buy
20-day SMA: 0.7 Buy
50-day SMA: 0.96 Buy
200-day SMA: 1.07 Buy
8-day EMA: 0.87 Buy
20-day EMA: 0.81 Buy
50-day EMA: 0.9 Buy
200-day EMA: 0.05 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.01 Buy
20-day SMA: 91.26 Buy
50-day SMA: 93.56 Buy
200-day SMA: 96.81 Buy
8-day EMA: 92.7 Buy
20-day EMA: 91.91 Buy
50-day EMA: 92.32 Buy
200-day EMA: 91.6 Buy

First Resources Earnings Growth & FTROF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

First Resources Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):